EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Successful Treatment of Large B-Cell Lymphoma in a Child with Compound Heterozygous Mutation in the ATM Gene

Jakub Czarny iD, Marta Andrzejewska, Olga Zając-Spychała, Elżbieta Latos-Grażyńska, Agata Pastorczak iD, Kamila Wypyszczak, Aleksandra Szczawińska-Popłonyk, Izabela Niewiadomska-Wojnałowicz, Agnieszka Wziątek, Patrycja Marciniak-Stępak, Michał Dopierała, Jadwiga Małdyk und 2 weitere

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24021099 ↗

Kurz gefasst

Fallbericht in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Jakub Czarny und 13 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Poznan University of Medical Sciences, 61-701 Poznań, Poland. Hauptthemen laut MEDLINE: Lymphoma, Large B-Cell, Diffuse, Ataxia Telangiectasia. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ataxia-telangiectasia (AT) is a multisystemic neurodegenerative inborn error of immunity (IEI) characterized by DNA repair defect, chromosomal instability, and hypersensitivity to ionizing radiation. Impaired DNA double-strand break repair determines a high risk of developing hematological malignancies, especially lymphoproliferative diseases. Poor response to treatment, excessive chemotherapy toxicities, and the need for avoiding exposure to ionizing radiation make the successful clinical management of patients with AT challenging for oncologists. We describe the favorable outcome of the LBCL with IRF4 rearrangement at stage III in a 7-year-old female patient diagnosed with AT. The patient was treated according to the B-HR arm of the INTER-B-NHL-COP 2010 protocol, including the administration of rituximab, cyclophosphamide, methotrexate, prednisone, etc. She presented excessive treatment toxicities despite individually reduced doses of methotrexate and cyclophosphamide. However, in the MRI there was no significant reduction in pathologic lymph nodes after three immunochemotherapy courses. Therefore, a lymph node biopsy was taken. Its subsequent histopathological examination revealed tuberculosis-like changes, though tuberculosis suspicion was excluded. After two following immunochemotherapy courses, PET-CT confirmed complete remission. From March 2022 onwards, the patient has remained in remission under the care of the outpatient children’s oncology clinic.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphoma, Large B-Cell, DiffuseAtaxia TelangiectasiaFemaleHumansChildMethotrexatePositron Emission Tomography Computed TomographyRituximabPrednisoneCyclophosphamideMutationAntineoplastic Combined Chemotherapy ProtocolsVincristineDoxorubicinAtaxia Telangiectasia Mutated Proteins

Stichwörter der Autor:innen

DNA repairLBCLataxia-telangiectasiarituximab

Substanzen

MethotrexateRituximabPrednisoneCyclophosphamideVincristineDoxorubicinATM protein, humanAtaxia Telangiectasia Mutated Proteins

Autor:innen und Institutionen

  • Faculty of Medicine, Poznan University of Medical Sciences, 61-701 Poznań, Poland.
  • Department of Pediatric Oncology, Hematology and Transplantology, Institute of Pediatrics, Poznań University of Medical Sciences, 60-355 Poznań, Poland.
  • Department of Pediatric Bone Marrow Transplantation, Oncology and Hematology, Wrocław Medical University, 50-556 Wrocław, Poland.
  • Department of Pediatrics, Oncology and Hematology, Medical University of Łódź, 91-738 Łódź, Poland.
  • Department of Pediatric Pneumonology, Allergy and Clinical Immunology, Institute of Pediatrics, Poznań University of Medical Sciences, 60-355 Poznań, Poland.
  • Department of Pathology and Clinical Immunology, Poznań University of Medical Sciences, 60-355 Poznań, Poland.

ORCID-Profile: Jakub Czarny, Agata Pastorczak, Katarzyna Jończyk-Potoczna, Katarzyna Derwich

Zitieren

APA

Czarny, J., Andrzejewska, M., Zając-Spychała, O., Latos-Grażyńska, E., Pastorczak, A., Wypyszczak, K., Szczawińska-Popłonyk, A., Niewiadomska-Wojnałowicz, I., Wziątek, A., Marciniak-Stępak, P., Dopierała, M., Małdyk, J., Jończyk-Potoczna, K., & Derwich, K. (2023). Successful Treatment of Large B-Cell Lymphoma in a Child with Compound Heterozygous Mutation in the ATM Gene. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24021099

Vancouver

Czarny J, Andrzejewska M, Zając-Spychała O, Latos-Grażyńska E, Pastorczak A, Wypyszczak K, et al. Successful Treatment of Large B-Cell Lymphoma in a Child with Compound Heterozygous Mutation in the ATM Gene. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24021099

BibTeX
@article{Czarny2023,
  author = {Czarny, Jakub and Andrzejewska, Marta and Zając-Spychała, Olga and Latos-Grażyńska, Elżbieta and Pastorczak, Agata and Wypyszczak, Kamila and Szczawińska-Popłonyk, Aleksandra and Niewiadomska-Wojnałowicz, Izabela and Wziątek, Agnieszka and Marciniak-Stępak, Patrycja and Dopierała, Michał and Małdyk, Jadwiga and Jończyk-Potoczna, Katarzyna and Derwich, Katarzyna},
  title = {Successful Treatment of Large B-Cell Lymphoma in a Child with Compound Heterozygous Mutation in the ATM Gene},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24021099}
}
Kostenlos starten →